Rutgers Cancer Institute, along with its partner
RWJBarnabas Health
, offers the most advanced cancer treatment options including complex robotic surgery, clinical trials and novel therapeutics such as precision medicine, CAR T-Cell Therapy and other forms of immunotherapy.
|
|
|
Rutgers Receives $4 Million to Accelerate Development of Biomedical Technologies
|
|
|
|
Rutgers University was selected as one of five new hubs under the National Institutes of Health’s Research Evaluation and Commercialization Hubs (REACH) program through a $4 million grant (U01HL150852). The aim is
to speed up the translation of biomedical discoveries into commercially viable diagnostics, devices, and therapeutics to improve patient care. Rutgers Cancer Institute of New Jersey Director,
Steven K. Libutti, MD, FACS
, vice chancellor of cancer programs at Rutgers Biomedical and Health Sciences and senior vice president of oncology services at RWJBarnabas Health; and
Renata Pasqualini, PhD
, chief of the Division of Cancer Biology in the Department of Radiation Oncology at Rutgers Cancer Institute and a professor of medicine at Rutgers New Jersey Medical School, are among the principal investigators on the grant.
Learn more
|
|
|
|
With a high-risk form of leukemia, Lael McGrath needed a stem cell transplant. Since no family members were a match, specialists in the Blood and Marrow Transplant Program at Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital New Brunswick quickly teamed up with the National Marrow Donor Program, Be the Match, where her ideal match was located in Germany. Nearly three years post-transplant, McGrath was able to thank her donor face-to-face during a recent heart-warming ceremony.
|
|
Rutgers Cancer Institute Leader Awarded American Cancer Society Cancer Research Professorship Grant
|
|
|
|
Yibin Kang, PhD
, the Warner-Lambert/Parke Davis Professor of Molecular Biology at Princeton University and the Associate Director for Consortium Research at Rutgers Cancer Institute of New Jersey, has been awarded an American Cancer Society Research Professorship, receiving a lifelong designation accompanied by a five-year $400,000 commitment. Researchers are selected for American Cancer Society professorships based on their history of pioneering, influential work that’s continuing to change the direction of cancer research and on their track record of mentoring people who have become successful in cancer research.
Learn more
|
|
Oncology Pharmacists: An Essential Partner in the Cancer Journey
|
|
|
|
One of the hallmarks of a National Cancer Institute-designated Comprehensive Cancer Center like Rutgers Cancer Institute of New Jersey, the only such designated center in the state, is the unique oncology expertise exhibited by its clinical team. This includes pharmacists who are board certified. Of the Board Certified Oncology (BCOP) Pharmacists in the state, ten percent practice at Rutgers Cancer Institute and RWJBarnabas Health. Michael P. Kane, RPh, BCOP, director of Oncology Pharmacy Services at Rutgers Cancer Institute shares more about how these specially certified professionals play an integral role in the management of patient care.
|
|
|
|
During this National Lung Cancer Awareness Month, experts from the
Rutgers Tobacco Dependence Program
– supported by Rutgers Cancer Institute, Rutgers School of Public Health and Rutgers Robert Wood Johnson Medical School – share more about the causes and risk factors for lung cancer, which include smoking. At focus is prevention, including tobacco cessation.
Learn more
|
|
|
|
|
|
|
